Tumor Infiltrating Lymphocytes: A New Frontier in Cancer Immunotherapy

Report Includes:

- An overview of Tumor Infiltrating Lymphocytes (TILs) for the treatment of metastatic cancer
- Discussion of the development of TIL as a treatment option for melanoma and the possibilities to expand this therapy to other types of cancer
- Exploration of adoptive T-cell therapy (ATCT) using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma, and the curative potential of ATCT in a variety of other solid tumors
- Comparison between two main technologies of tumor immunotherapy, chimeric antibody receptor engineered T Cell (CAR-T) and genetically modified T cell receptors (TCR)
- Information on the role of TILs as a strong prognostic biomarker for triple-negative breast cancer (TNBC) and their potential ramifications

Chapter 1 The Emergence of Cell Therapy Using TILs
Analysts Credentials
Related Reports
Chapter 2 Development of TIL Therapies in Metastic Melanoma
TIL Generation Explained
Importance of Lymphodepletion
Role of Interleukin-2
Feasibility of TIL as a Mainstream Treatment Option
Chapter 3 Development of TIL Therapies in Other Tumour Types
Cervical Cancer
Ovarian Cancer
Kidney Cancer
Gastrointestinal Cancer
Head and Neck Cancers
Chapter 4 Clinical Development of TIL Therapies
Lifileucel (LN-144), Iovance Biotherapeutics
LN-145, Iovance Biotherapeutics
TILT-123, TILT Biotherapeutics
Optera Therapeutics Corp.
Other Centers Conducting TIL Research
Future Perspectives for TIL
Chapter 5 References

List Of Tables

Table 1 : TILs and Tumor Specific Antigens
Table 2 : Adoptive T-Cell Therapy (ATC) Cellular Therapies
Table 3 : Clinical Trials Studying TIL Therapies

List Of Figures

Figure 1 : Generation of Tumor Infiltrating Lymphocytes
Figure 2 : IL-2 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types
Figure 3 : TILT Biotherapeutics Development Pipeline

Europe Tumor Marker Diagnostics Market, 2019-2023: France, Germany, Italy, Spain, UK--Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Instrumentation Review, Technology Trends, Opportunities for Suppliers

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The

USD 14500 View Report

South Africa Clinical Chemistry and Immunodiagnostic Markets 2018-2023: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities for Suppliers

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five

USD 3750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available